Navigation Links
Genetic pathways to curable and incurable forms of pancreatic cancer identified

Pancreatic ductal adenocarcinoma is an almost uniformly fatal disease regardless of the stage at time of diagnosis. However, a small percentage of patients develop a form of ductal adenocarcinoma associated with cystic lesions that can be detected earlier, is less aggressive and has a 50 percent long-term survival rate. Why cystic ductal pancreatic cancer behaves differently, despite carrying the same basic genetic mutations as the more common and deadly type of ductal pancreatic cancer, has long been a mystery. Now researchers at Fred Hutchinson Cancer Research Center have unlocked the genetic reason why.

Using unique mouse models to mimic the progression of both forms of human pancreatic cancer, researchers have discovered that a specific sequence of otherwise common genetic mutations is responsible for sending cells down the less-traveled path toward cystic pancreatic cancer versus the well-traveled route to the more fatal form of ductal pancreatic cancer.

Sunil Hingorani, M.D., assistant member of the Hutchinson Center's Clinical Research and Public Health Sciences divisions, led a study to be published in the March 12 issue of the journal Cancer Cell that explains this sequence and details why the cells behave differently.

"Although at their end stage the two different routes to ductal pancreatic cancer can look very much the same under the microscope, involve the same constellation of genetic events, and culminate in invasive and metastatic disease that can ultimately kill patients, one route is 100 percent fatal while the other is 50 percent curable," Hingorani said. "Until now we didn't understand why. What these studies suggest is that it's not just the total complement of mutations that determines the behavior of these cancers but also the sequence in which the mutations arise."

About 5 percent of all primary tumors of the pancreas, out of 40,000 annual new cases in the United States, arise from cystic tumors.

'"/>

Source:Fred Hutchinson Cancer Research Center


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Ants Genetic Engineering Leads To Species Interdependency
4. Genetic Variation Visualization - From EMBL
5. Genetically modified rice in China benefits farmers health, study finds
6. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
7. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
8. Genetic defects give the immune system the green light to attack the pancreas
9. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
10. Genetic therapy reverses nervous system damage in animal model of inherited human disease
11. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells

Post Your Comments:
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aure...annihilation as low-temperature plasma prototype d...asy and unfailing bactericidal cocktails. , Two ...icient disinfection of healthy skin (e.g. hands an...ria can pose a lethal threat; and another to shoot...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In ...the bugs, they have natural enemies called bacteri...rth every two days. , Still, bacteria and anoth...iscovered in extreme environments such as deep-sea...art because they have a built-in defense system th...
(Date:11/25/2009)... MADISON, WI, NOVEMBER 25, 2009 Soil is the linc...re, and hydrosphere meet. Despite that, many stude...s, but nothing more. Soil science educators are ch... public recognize the critical importance of soil ...y soil science and earth science teachers at Unive...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 1Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 1Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 3Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3
...c? If you,re a health care professional you,d bett...n estimated 1.3 million people in the United State...rs, and the U.S. Federal Drug Administration (FDA)...hese errors, such as a documented case in which a ... Norcuron and went into cardiac arrest. , A few ...
...evelopment, Dr. Mary Ellen Perry and colleagues va...get for cancer therapies. , The p53 tumor suppress...many anticancer strategies aim to activate p53 in ...itor of p53 and therefore an attractive target to ...ng evidence exists regarding whether or not p53-me...
... death by suicide generally decreases in the weeks...tion, according to a new study led by Group Health...ary issue of The American Journal of Psychiatry. T...vior after starting 10 newer antidepressant medica...ions. , These findings challenge a 2004 advisory ...
Other Biology News:Computer scientist sorts out confusable drug names 2Suicide risk does not increase when adults start using antidepressants, study finds 2
(Date:11/30/2009)...iding smart and efficient software to the preclini...olutionizing work-from-home histopathology by util...e used by 8 of the Top 10 Pharmaceutical Companies...o; basis. , Mount Arlingt...ced another evolution in the histopathology realm ...
(Date:11/30/2009)...DAM, November 30 Elsevie...dical and technical products and services,today a...nsive biomedical,database which holds over 20 mill...eer reviewed journals. , Embase has long ...ical,and pharmaceutical insights. Now, new develop...
(Date:11/27/2009)...e test alternative is helping bring complete auto...ser for pharma-companies. It is a non-destructive,...Sepha for use with blister packs and it has alrea...ma-companies such as Sanofi-Avenis and Zydus-Cadil...mprovements on the packaging line. Blisterscan ...
(Date:11/25/2009)...N, Fla., Nov. 25 For many business...ogicMD. The nation,s largest and fastest growing ...ely in medically supervised bioidentical hormones...twork since November 2008 - from 21 to 36 physi...owned centers, including one in Puerto Rico, by th...
Breaking Biology Technology:Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
... Feb. 25 The International,Confocal Microscopy Wo...ssionals and students, has been formed as a means ...lective confocal microscopy (RCM) in,patient care....bers worldwide.,Dermatologists, dermascopists, der...ssionals interested in learning more about RCM sho...
...25 Barr Pharmaceuticals,Inc. (NYSE: BRL ) today ...cals, Inc., has received notification that the U.S...for review its New Drug Application,(NDA) for Lo S...lets 0.10,mg/0.02 mg and ethinyl estradiol tablets...ompany is seeking approval to manufacture and mark...
.... 25 Nile Therapeutics,Inc. (OTC Bulletin Board: ...eveloping therapies for cardiovascular disease, is...Lieu, M.D., F.A.C.C. as its Vice President of,Clin...eu to Nile. Dr. Lieu has extensive,cardiovascular ...mmediately,beneficial to Nile and our CD-NP and 2N...
Other Biology Technology:International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 3Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 4Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 3
Anti-G Protein Gq / 11a Subunit, Internal Sequence, a.a. 115-133 Polyclonal Antibody, Unconjugated from CHEMICON
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Biology Products: